Today: Today, Opko Health Inc. (OPK) CEO Buys $37,476.00 in Stock

Today, Opko Health Inc. (OPK) CEO Buys $37,476.00 in Stock

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost purchased 3,600 shares of the company’s stock in a transaction on Monday, November 21st. The shares were purchased at an average cost of $10.41 per share, with a total value of $37,476.00. Following the purchase, the chief executive officer now owns 3,068,951 shares of the company’s stock, valued at $31,947,779.91. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Phillip Md Et Al Frost also recently made the following trade(s): On Tuesday, November 22nd, Phillip Md Et Al Frost purchased 5,400 shares of Opko Health stock. The shares were purchased at an average cost of $10.28 per share, with a total value of $55,512.00. On Friday, November 18th, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The shares were purchased at an average cost of $10.38 per share, with a total value of $18,684.00. On Wednesday, November 16th, Phillip Md Et Al Frost purchased 4,300 shares of Opko Health stock. The shares were purchased at an average cost of $10.13 per share, with a total value of $43,559.00. On Friday, November 11th, Phillip Md Et Al Frost purchased 14,600 shares of Opko Health stock. The shares were purchased at an average cost of $9.46 per share, with a total value of $138,116.00. On Wednesday, November 9th, Phillip Md Et Al Frost purchased 5,400 shares of Opko Health stock. The shares were purchased at an average cost of $9.33 per share, with a total value of $50,382.00. On Tuesday, November 8th, Phillip Md Et Al Frost purchased 23,100 shares of Opko Health stock. The shares were purchased at an average cost of $9.22 per share, with a total value of $212,982.00. On Wednesday, November 2nd, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The shares were purchased at an average cost of $9.48 per share, with a total value of $94,800.00. On Tuesday, November 1st, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The shares were purchased at an average cost of $9.49 per share, with a total value of $94,900.00. On Monday, October 31st, Phillip Md Et Al Frost purchased 11,800 shares of Opko Health stock. The shares were purchased at an average cost of $9.43 per share, with a total value of $111,274.00. On Friday, October 28th, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The shares were purchased at an average cost of $9.46 per share, with a total value of $94,600.00.

Opko Health Inc. (NASDAQ:OPK) opened at 10.70 on Friday. Opko Health Inc. has a 12-month low of $7.12 and a 12-month high of $11.85. The firm’s 50 day moving average price is $9.76 and its 200-day moving average price is $9.87. The stock’s market cap is $5.97 billion.

Opko Health (NASDAQ:OPK) last issued its quarterly earnings data on Monday, November 7th. The company reported ($0.03) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.03). The firm earned $298 million during the quarter, compared to analyst estimates of $322 million. Opko Health had a negative return on equity of 0.49% and a negative net margin of 0.81%. The business’s quarterly revenue was up 108.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.25 earnings per share. Equities research analysts anticipate that Opko Health Inc. will post ($0.08) earnings per share for the current fiscal year.

A number of equities research analysts have recently weighed in on OPK shares. JPMorgan Chase & Co. set a $14.00 target price on Opko Health and gave the company a “buy” rating in a research note on Tuesday, August 9th. Zacks Investment Research raised Opko Health from a “sell” rating to a “hold” rating in a research report on Tuesday, October 25th. Oppenheimer Holdings Inc. reaffirmed a “hold” rating on shares of Opko Health in a research report on Monday, October 10th. Jefferies Group reaffirmed a “hold” rating and set a $10.00 price target on shares of Opko Health in a research report on Monday, October 10th. Finally, TheStreet lowered Opko Health from a “hold” rating to a “sell” rating in a research report on Wednesday, November 9th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $13.17.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Whalerock Point Partners LLC purchased a new position in shares of Opko Health during the third quarter worth $2,100,000. Piedmont Investment Advisors LLC bought a new position in Opko Health during the third quarter valued at approximately $622,000. Price T Rowe Associates Inc. MD raised its position in Opko Health by 3.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 947,871 shares of the company’s stock valued at $10,038,000 after buying an additional 28,700 shares in the last quarter. Finally, LPL Financial LLC raised its position in Opko Health by 3.9% in the third quarter. LPL Financial LLC now owns 13,374 shares of the company’s stock valued at $142,000 after buying an additional 504 shares in the last quarter. Hedge funds and other institutional investors own 20.33% of the company’s stock.

About Opko Health

OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.

Receive News & Ratings for Opko Health Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Opko Health Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment